A systematic review and meta-analysis titled "Hypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis" was published on 2026-07-31. The publication appeared in the journal Endocrine.
Albiglutide is referenced within this GLP-1 receptor agonist class analysis. Albiglutide remains classified as an unapproved research compound.
The publication is indexed under PubMed ID 42536323. No specific findings, effect sizes, or conclusions from the review are detailed here beyond its title and publication venue.
This entry reflects only the existence and bibliographic details of the new publication. Readers interested in the broader context of albiglutide, including its regulatory status and general background, can consult the compound overview for additional information.